Dr. Alphonse Taghian, Professor of Radiation Oncology at Harvard Medical School, earned his Medical Degree from Alexandria University in Egypt. He completed his residency in Radiation Oncology in France, after which he pursued clinical and research fellowships at Gustave-Roussy Institut, Paris.
After obtaining his Ph.D. in Radiobiology from Paris XI University, Dr. Taghian was appointed as staff in the Department of Radiation Oncology at Massachusetts General Hospital. He is now the Director of the Lymphedema Research Program and Co-Director of the Breast Cancer Research Program at Massachusetts General Hospital.
An internationally recognized leader in breast radiation oncology, in particular in the field of Accelerated Partial Breast Irradiation (APBI), Dr. Taghian has published more than 250 peer-reviewed articles, general reviews, and chapters. He has edited two books. He was awarded several NIH grants totaling around $2.7 Million for research in breast cancer-related lymphedema.
Interest/specialization: Screening and early intervention for lymphedema, methods to minimize cardiac exposure to radiation, accelerated partial breast irradiation, the impact of radiation on breast reconstruction, and indications for post-mastectomy radiation.